000 02399 a2200805 4500
005 20250516165622.0
264 0 _c20140430
008 201404s 0 0 eng d
022 _a1476-5551
024 7 _a10.1038/leu.2013.253
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBachanova, V
245 0 0 _aPh+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease.
_h[electronic resource]
260 _bLeukemia
_cMar 2014
300 _a658-65 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAnimals
650 0 4 _aBone Marrow Transplantation
650 0 4 _aFemale
650 0 4 _aGuinea Pigs
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm, Residual
650 0 4 _aPhiladelphia Chromosome
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xpathology
650 0 4 _aProtein-Tyrosine Kinases
_xantagonists & inhibitors
650 0 4 _aRemission Induction
650 0 4 _aSurvival Rate
650 0 4 _aTransplantation Conditioning
650 0 4 _aTransplantation, Homologous
650 0 4 _aYoung Adult
700 1 _aMarks, D I
700 1 _aZhang, M-J
700 1 _aWang, H
700 1 _ade Lima, M
700 1 _aAljurf, M D
700 1 _aArellano, M
700 1 _aArtz, A S
700 1 _aBacher, U
700 1 _aCahn, J-Y
700 1 _aChen, Y-B
700 1 _aCopelan, E A
700 1 _aDrobyski, W R
700 1 _aGale, R P
700 1 _aGreer, J P
700 1 _aGupta, V
700 1 _aHale, G A
700 1 _aKebriaei, P
700 1 _aLazarus, H M
700 1 _aLewis, I D
700 1 _aLewis, V A
700 1 _aLiesveld, J L
700 1 _aLitzow, M R
700 1 _aLoren, A W
700 1 _aMiller, A M
700 1 _aNorkin, M
700 1 _aOran, B
700 1 _aPidala, J
700 1 _aRowe, J M
700 1 _aSavani, B N
700 1 _aSaber, W
700 1 _aVij, R
700 1 _aWaller, E K
700 1 _aWiernik, P H
700 1 _aWeisdorf, D J
773 0 _tLeukemia
_gvol. 28
_gno. 3
_gp. 658-65
856 4 0 _uhttps://doi.org/10.1038/leu.2013.253
_zAvailable from publisher's website
999 _c23044894
_d23044894